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ABSTRACT
The middle of the 20th century hailed the realization
that patients with Hodgkin disease could be cured.
Through the groundbreaking work of Vera Peters, pa-
tients with a localized form of the disorder, previously
thought to be incurable, were shown to be cured by
extended-field radiotherapy. This important observa-
tion, although not immediately accepted, opened the
minds of physicians to take more positive investiga-
tive and therapeutic approaches. Peters also introduced
and championed the concept of tumour staging in
Hodgkin disease and the use of prognostic factors in
clinical decision-making. This novel approach led to
high cure rates with radiotherapy in localized disease
and provided a scientific basis for the subsequent use
of chemotherapy in disseminated disease, resulting in
a very high cure rate in patients with all stages of
Hodgkin disease.
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1. INTRODUCTION
1.1 The Initial Descriptions of Hodgkin Disease
In 1666 Marcello Malpighi, an Italian physician and
scientist, was the first to describe a disease of lymph
nodes and spleen that was uniformly fatal. In 1832,
Thomas Hodgkin wrote about the gross pathology of
seven such cases. Subsequently, in 1856 and 1865,
Samuel Wilks described more cases, which included
several from Hodgkin’s report. They both worked at
Guy’s Hospital in London, England, although Hodgkin
had retired in 1837 and it is unlikely that the two knew
one another. However, Wilks recognized Hodgkin’s
1832 observations and attached the eponym Hodgkin
disease to the disorder. By the early 20th century, Stern-
berg, Reed, and others were describing the microscopic
pathology that is accepted as characteristic of Hodgkin
disease 1–3.
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1.2 Early Radiation Treatment of Hodgkin Disease
No reports of effective treatment for Hodgkin disease
appeared until 1902, when Pusey reported that enlarged
lymph nodes in patients with Hodgkin disease could be
resolved by exposure to X rays 4. That publication was
quickly followed by a Canadian report documenting
similar findings in a single case later that same year 5.
René Gilbert of Geneva, Switzerland, made a
major contribution in 1939 when he reported on a 17-
year experience treating Hodgkin disease patients with
radiation therapy. He developed a new approach that
involved treating lymph node areas separately, and he
administered radiation to multiple regions, not only to
those involved with disease. Because of the severe skin
reactions observed at high radiation doses, Hodgkin
patients were generally treated to lower doses of ra-
diation. Gilbert’s equipment was of low voltage (70–
200 kV), and despite the use of low doses, he
documented the disappearance of lymph nodes and
mediastinal masses. Fever often resolved, and patients
experienced weight gain and improvement in anemia.
Gilbert calculated that survival was approximately
doubled, but he emphasized that radiation treatment
failed to cure the patients—relapses occurred 6.
In Toronto, Gordon Richards, a radiation treatment
pioneer in North America, installed a 400-kV radia-
tion machine at the Ontario Radiotherapy Institute at
the Toronto General Hospital in 1937 7. This machine
was considered superior to Gilbert’s equipment. The
higher energy provided some skin sparing, which per-
mitted the delivery of higher doses at depth within the
thorax and abdomen. Richards was apparently influ-
enced by Gilbert, because he gave added treatment to
lymphatic regions with no obvious disease that were
adjacent to the enlarged and involved lymph nodes.
2. MILDRED VERA PETERS AND HODGKIN
DISEASE
2.1 Vera’s Early Days a
Mildred Vera Peters (always known as Vera) was born
in 1911 and brought up on a farm. She received her
a Information in this and later sections about the life of Vera Peters
was obtained from the archives of the University of Toronto; theCOWAN
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elementary education in a one-room school house. Af-
ter high school, she enrolled in the Faculty of Medi-
cine, University of Toronto, and graduated with her MD
in 1934. During medical school days, she met her fu-
ture husband. Their subsequent marriage was highly
successful. Vera demonstrated how to balance an ex-
tremely productive career with a happy and successful
family life. She became a role model for young women
entering the medical profession.
Vera interned for one year at St. John’s Hospital, a
women’s surgical hospital, in Toronto, where she saw
a large number of patients with malignant disease. In
1935, she joined Dr. Gordon Richards at the Radio-
therapy Institute in the Toronto General Hospital. She
had heard lectures by Richards during medical school,
and she also came to know him when he treated her
mother for breast cancer. No formal training program
in radiotherapy existed at the time; Peters worked as
an apprentice, with Richards as her mentor 8. In 1937,
the same year that the 400-kV machine was installed
at the Toronto General Hospital 7, she joined the full-
time staff as a junior assistant radiotherapist 9. Peters
was one of the first women to have a clinical appoint-
ment in a Toronto teaching hospital. The association of
Vera Peters and Gordon Richards proved to be of enor-
mous importance to future knowledge about the man-
agement of patients with Hodgkin disease.
2.2 The Hodgkin Disease Story
For the first 10 years after her appointment, Peters
worked with her mentor, seeing a wide range of pa-
tients and continuing to mature and hone her clinical
and radiotherapy skills. She gradually became respon-
sible for treating a large number of patients, including
those with Hodgkin disease.
One day in 1947, Richards encountered Peters in
the hallway at the Institute, addressed her in his usual
formal manner, saying, “Dr. Peters, how would you
like to review our experience with Hodgkin’s disease?
All the textbooks say it is a fatal disease, but we seem
to be seeing patients who are cured” 8. In later years,
Peters reflected on that encounter: “That was the be-
ginning of my career.... the more I learned about
[Hodgkin disease] from charts and patients, the more I
wanted to know” 8.
This was the start of two years of intensive work
and, indeed, the beginning of Peters’s very productive
academic career. She cared for patients during the day
and brought records and patient files home at night and
on weekends. Many hours were spent working at the
dining room table. All the work was done by hand in
this pre-computer era.
By 1949, Peters had completed the review and pre-
sented her findings to colleagues at the Toronto Gen-
eral Hospital. Unfortunately, Richards had died in
January 1949, before Peters completed her work, and
he was not aware of the outcome of the study he had
suggested.
The results of radiation treatment in 113
histologically proven cases of Hodgkin disease (all re-
viewed by an expert pathologist) appeared in Peters’s
1950 landmark publication 10. Three extremely impor-
tant messages appeared in that report:
￿ The importance of a staging system. By group-
ing patients according to their ultimate survival,
Peters developed the first clinical classification
(staging system) for patients with Hodgkin disease.
The extent of disease on presentation appeared to
be the most striking common factor influencing
survival. Peters also noted the negative prognostic
consequence of constitutional symptoms (includ-
ing fever and weight loss). Table I shows the origi-
nal Peters staging system. Hers was a three-stage
classification, depending on the extent of demon-
strable disease. The current four-stage classifica-
tion b is based on that three-stage foundation. This
contribution by Peters provided a method for com-
paring various patient series and treatment results.
It also provided the first rational basis for planning
treatment.
￿ Prolongation of survival. Patients at the To-
ronto General Hospital experienced superior sur-
vival as compared with patients previously
reported. For the whole group of patients, 5-year
survival doubled, and 10-year survival more than
tripled. Peters showed that the survival curve flat-
tened at about the 8- to 9-year mark. The median
survival for stage I patients was more than 11.6
years; for stage II patients, it was more than 7.8
years; and for stage III patients, it was 1.9 years.
Patients with stage I disease had a 5-year survival
of 88% and a 10-year survival of 79%. These data
were sufficient to suggest the possibility of a cure
in patients with stage I disease. Although cure was
implied, Peters did not make this claim in her first
paper. Rather, she emphasized a more optimistic
attitude toward prognosis in early cases if properly
treated.
￿ Radiation treatment. Intensive irradiation of
involved lymph nodes combined with precaution-
ary treatment of the nodes adjacent to the involved
area was required to bring about improved survival
rates in patients with stage I disease.
b The original classification by Peters was a three-stage system.
The current classification has a number of refinements for each
of stages I–III and also adds stage IV: involvement of one or more
extranodal tissues (for example, liver or bone marrow). A suffix
indicates the absence (A) or presence (B) of systemic symptoms
such as fever or weight loss.
University Health Network Archives (Princess Margaret Hos-
pital fonds); Torontonensis (the University of Toronto year-
book) 1928 to 1934; the calendars of the Faculty of Medicine,
University of Toronto, 1928 to 1934; family files and photograph
albums; and interviews with Peters’s daughters (Ms. Sandra Clark,
Dr. Jennifer Ingram) and other relatives, colleagues, and friends.THE CURABILITY OF HODGKIN DISEASE
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An interested observer was Dr. Lillian Fuller. She
became a renowned radiation oncologist at the M.D.
Anderson Hospital in Houston, Texas, and an expert in
the radiation treatment of Hodgkin disease. She had
started her training in therapeutic radiology in the early
1950s in Rochester, New York. Fuller was aware of
the 1950 paper, and she travelled to Toronto to meet
and talk with Peters. In later years, Fuller commented
that “Peters’ paper set the world on fire. Although oth-
ers—for example, Gilbert—had probably cured some
cases, it was Peters who demonstrated to the world that
Hodgkin’s disease could be cured. No one could relate
cure to stage and treatment as Vera Peters did” 11.
Nevertheless, the general response to the 1950 re-
port was lukewarm. As Peters herself put it, “I could
demonstrate [the potential for cure] on a statistical ba-
sis from the survival curves. As soon as you demon-
strate something that is not part of a common belief,
you run up against a lot of disbelief.... It was about ten
years before it caught on—before they started to be-
lieve” 8. In the late 1950s, a Toronto physician doing
postgraduate training in London, England, was greeted
with a chuckle, a nudge, and the remark “Oh, you are
from that place where it is believed Hodgkin’s disease
can be cured!” 12
In 1956, Peters presented an update of her work
at a conference in Mexico City. That update, which
confirmed and built on her previous publication, was
published two years later 13. The series now included
291 cases of Hodgkin disease. Cure seemed even
more likely. The article stated that “a ten-year sur-
vival without reoccurrence after the initial control is
necessary before one can be reasonably confident of
a cure.”
The concept of cure was still not widely accepted;
it remained for others to confirm Peters’s work. Im-
portant among these researchers were Easson and
Russell of the Holt Radium Institute in Manchester,
England. In 1963, Easson and Russell published a pa-
per in which they made the case for the curability of
Hodgkin disease 14, finally garnering acceptance by
practitioners working in the field. However, wide-
spread dissemination of information on curability took
somewhat longer. A survey of the eight editions, from
1950 to 1977, of a popular and highly respected gen-
eral medical textbook, Harrison’s Principles of In-
ternal Medicine, revealed no mention of the curability
of Hodgkin disease until the 1970s. The 1974 edition
makes this statement: “The goal of therapy in Hodg-
kin’s disease should be to cure.... [T]he hope that
Hodgkin’s can be cured was spurred by the experi-
ence of Peters” 15.
2.3 Further Progress by Peters and Others
After Peters made her major contribution to the con-
trol of Hodgkin disease, she began spending an increas-
ing amount of time on her other major interest, breast
cancer. But she maintained an intense interest in
Hodgkin disease and published on the subject through-
out her career. Of special interest were her observa-
tions about patterns of disease. She had observed these
patterns in a large group of patients, first at the Ontario
Radiotherapy Institute at the Toronto General Hospi-
tal, and later when patients and staff transferred to the
new Princess Margaret Hospital in 1958. She had the
great advantage of working in a large referral centre
from which she could follow many patients in a longi-
tudinal manner for many years. The pattern of lymph
node involvement frequently allowed Peters to predict
the results of investigations, including exploratory
laparotomy, and to predict prognosis on the basis of an
initial examination of a patient. To many, her predic-
tions appeared intuitive, but of course they were based
on the many observations she had made in numerous
patients. For example, Peters observed that a patient
presenting with a cluster of small lymph nodes meas-
uring less than a centimetre in diameter in the periph-
eral regions of the upper torso predicted widespread
disease. At exploratory surgery of the abdomen in such
patients, disease would frequently be found even in
small mesenteric lymph nodes. The disease in these
patients was difficult to control, particularly with ra-
diation treatment. In contrast, patients presenting with
a limited number of discrete larger nodes in peripheral
regions were more likely to be controlled by radiation
alone and had a much better prognosis than did the
former group 16,17.
Other examples of her wide interest in Hodgkin
disease are reflected in important papers by Peters on
the treatment of non-involved lymph node areas adja-
cent to the site of known disease 18 and the contribution
of lymphangiography 17 to staging and the detection of
deep-seated lymph nodes. Through the years, Peters
continued to give many talks nationally and internation-
ally on the subject of Hodgkin disease, and even into
her retirement years, she was a sought-after consultant.
Once the curability of Hodgkin disease was estab-
lished, it remained for others to carry the torch further.
Henry Kaplan and his colleagues at the Stanford
University Medical School played a most important
role in consolidating advances in radiotherapy and the
general approach to Hodgkin disease 19. At the same
time, DeVita and colleagues at the National Cancer
Institute in Bethesda, Maryland, demonstrated that
TABLE I Peters’ original staging classifications 10
Stage I Involvement of a single lymph node region or a single lesion elsewhere in the body
Stage II Involvement of two or more proximal lymph node regions of either the upper or lower trunk
Stage III Involvement of two or more lymph node regions of both upper and lower trunkCOWAN
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combination chemotherapy could cure patients with ad-
vanced Hodgkin disease that was not curable with ra-
diation alone 20. Further progress has allowed for
approximately 80% of patients with all stages of
Hodgkin disease to achieve cure 21.
For her outstanding contributions to the control of
Hodgkin disease and her work with breast cancer pa-
tients, Vera Peters received a host of honours and
awards. These included lectureships, honorary degrees,
medals from prestigious oncology organizations in the
United States and Europe, and the highest honour that
can be bestowed upon a Canadian—the Order of
Canada. Peters’s retirement included valued and en-
joyable time with friends, family, and especially her
grandchildren. Peters died of metastatic cancer in 1993
in the Princess Margaret Hospital, the institution she
served so well for so many years.
3. DISCUSSION
What role did Peters take in this evolution of a cure for
patients with Hodgkin disease?
There is no doubt that her work has been acclaimed
internationally, both in North America and in Europe.
In a chapter on Hodgkin disease in Principles and Prac-
tice of Oncology, Vincent P. DeVita Jr., Peter M. Mauch,
and Nancy Lee Harris say that “in her landmark paper
published in 1950 in the American Journal of
Roentgenology, Peters provided evidence that patients
with limited Hodgkin’s disease could be cured with
aggressive radiation therapy” 22.
Just after Peters’s retirement in 1976, Henry Kaplan
of Stanford University, at times a competitor, acknowl-
edged that “twenty-five years ago, Dr. Peters intro-
duced the first meaningful method of classifying the
stages of the disease and by 1960 was getting the best
results in the world with treatment by radiation” 23.
Sir David Smithers, Head of the Department of
Radiotherapy at the Royal Marsden Hospital and In-
stitute of Cancer Research in London, England, in his
review of the changes in the management of Hodgkin
disease over his 40-year career credited René Gil-
bert for beginning the work in the 1920s and 1930s,
Vera Peters for the work published in 1950 and later
updated, and Henry Kaplan and his group for consoli-
dating these advances. With regard to Peters, Smithers
said, “Building on the work Richards started, Dr. Vera
Peters proceeded with system and sense to develop a
planned radiotherapeutic attack on this disease proc-
ess. This quiet, determined, and charming lady has
written and spoken on the subject of Hodgkin’s dis-
ease with clarity and persistence for a number of
years. She showed us the importance to prognosis both
of the anatomic extent of disease and its constitutional
symptoms; she established a clinical staging system,
compared the results of local treatment and treatment
extended to adjacent lymph node regions apparently
uninvolved.... Through her, the approach of the medical
profession to the disease was changed in two impor-
tant respects: the staging system secured a better com-
parison of the results of treatment, and a more hopeful
outlook was encouraged amongst her contemporar-
ies” 19. In the dedication of his 1973 book on the dis-
ease, Smithers added, “Three people have done more
to improve the results of treatment for patients with
Hodgkin’s disease than any others.... this book is dedi-
cated to Vera Peters, Henry Kaplan and to the memory
of René Gilbert” 24.
It remains necessary to discuss one criticism that
has been put forward by a few people. The criticism is
that the patients were treated by Richards; Peters was
an assistant and was merely given the opportunity to
study the patients. The implication was that she has
received too much of the credit. It is true that the early
patients particularly were treated entirely by Richards,
using a technique based on Gilbert’s work. However,
when Richards introduced Peters to the question of
curability, she immediately saw the importance of
studying the problem and analyzing the data, and she
did so! She developed the first staging system, and she
demonstrated that early-stage Hodgkin disease could
be cured with an adequately high dose of radiation. In
other words, she related curability to early stage and
aggressive radiation. Peters herself points out that she
was building on the work of others (as do most clinical
investigators). In the introduction to one of her papers
addressing the evolution of the use of radiotherapy in
Hodgkin disease, Peters wrote that “my interpretation
of this evolution has been gleaned from the masterful
writing of Gilbert and from my earlier experiences as
a pupil of one of the esteemed pioneers of radiotherapy
in this country, the late Dr. Gordon Richards” 18.
Once when asked whether she was a pioneer in
Hodgkin disease, Peters modestly replied, “Well, I
consider Dr. Richards to be the pioneer. It was his work,
his optimism and because he kept good records that I
was able to demonstrate this.... I learned firsthand from
a very ingenious, kindly man, who I’m sure was a gen-
ius. He was the one who inspired.... Yes, he inspired
me. After that I needed no further inspiration. The in-
spiration came from within from then on” 8.
With those words, Vera Peters acknowledged her
mentor and chief, and in so doing, recorded an appro-
priate recognition of the past. Through her publications
and her work with patients who had Hodgkin disease,
she etched an indelible contribution for the future.
4. SUMMARY
Until the 1950s, Hodgkin disease was considered to be
incurable. Vera Peters dispelled this gloomy prognosis
for patients with early-stage disease. She carried out a
careful review of histologically proven cases and es-
tablished a three-stage classification. Further, she dem-
onstrated that patients with stage I disease could be
cured with aggressive radiation treatment.THE CURABILITY OF HODGKIN DISEASE
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